Sanofi's Dengue Vaccine Is World's First Approved

The first vaccine against the world's fastest growing mosquito-borne disease, dengue virus, has been granted marketing authorisation in Mexico. Sanofi Pasteur's Dengvaxia has been approved for prevention against four dengue virus serotypes in adults, adolescents and pre-adolescents, aged 9-45 years, by the COFEPRIS (The Federal Commission for the Protection against Sanitary Risks).